Colgate Palmolive Co
Colgate Palmolive Co (CL) is listed on NYSE and classified in Household & Personal Products, part of the Consumer Defensive sector. It is headquartered in New York, United States and has 33,600 employees. The company is worth $77.64B and trades at 36.8x its earnings of the last twelve months; the median for its sector is 18.2x. Revenue was $20.38B in fiscal 2025, up 1.4% from the year before. Net income was $2.13B. The share price is within 3% of its 52-week high. It pays a dividend yielding 2.18%, and has raised its annual dividend for 28 years in a row in our records. 7 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Cliff Asness (AQR Capital Management), at $426.78M. In that quarter, 5 of them opened or added to the position and 1 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▲ +25.4% over 5Y.
today you would have $1,383.19▲ +38.3%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 19 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $79.02 | $90.91 | $79.71 | $78.79 | $85.34 | $85.51 | $68.84 | $59.52 | $75.45 | $65.44 | $66.62 | $69.19 | $65.21 | $52.27 | $46.19 | $40.19 | $41.08 | $34.27 | $38.98 | |
| P/E | 25.9x | 30.0x | 25.9x | 28.8x | 37.0x | 33.5x | 27.2x | 25.0x | 21.6x | 33.1x | 24.1x | 43.8x | 29.3x | 27.4x | 20.3x | 18.7x | 18.6x | 18.8x | 18.7x | 24.4x |
| P/S | 3.4x | 3.1x | 3.7x | 3.4x | 3.6x | 4.1x | 4.4x | 3.8x | 3.3x | 4.3x | 3.8x | 3.7x | 3.6x | 3.4x | 2.9x | 2.6x | 2.6x | 2.6x | 2.2x | 2.9x |
| P/B | 76.2x | 1172.9x | 348.0x | 107.7x | 163.2x | 117.8x | 97.7x | 503.1x | — | — | — | — | 54.8x | 26.0x | 22.3x | 18.7x | 14.8x | 13.0x | 17.9x | — |
| EPS | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.14 | $2.75 | $2.75 | $2.28 | $2.72 | $1.52 | $2.36 | $2.38 | $2.57 | $2.47 | $2.16 | $2.19 | $1.83 | $1.60 | |
| Dividend yield | 2.28% | 2.61% | 2.18% | 2.40% | 2.36% | 2.10% | 2.05% | 2.48% | 2.79% | 2.11% | 2.37% | 2.25% | 2.05% | 2.04% | 2.33% | 2.46% | 2.53% | 2.09% | 2.28% | 1.80% |
| Payout | 56.99% | 78.33% | 56.41% | 68.95% | 87.32% | 70.20% | 55.73% | 62.18% | 60.36% | 69.74% | 56.99% | 98.68% | 60.17% | 55.88% | 47.47% | 45.95% | 47.10% | 39.36% | 42.62% | 43.75% |
| Profit margin | 13.10% | 10.46% | 14.37% | 11.82% | 9.93% | 12.43% | 16.36% | 15.08% | 15.44% | 13.10% | 16.06% | 8.63% | 12.62% | 12.86% | 14.47% | 14.53% | 14.15% | 14.95% | 12.77% | 12.60% |
| ROE | 273.03% | 3948.15% | 1362.74% | 377.67% | 445.14% | 355.67% | 362.72% | 2023.08% | — | — | — | — | 190.39% | 97.22% | 112.93% | 102.36% | 82.36% | 73.52% | 101.77% | — |
Median of the years shown; P/E years above 200x are left out.
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Median P/E of 18.2 among peers in the sector.
Median P/E of 25.9 across this company’s own years on record.
Cash flow growing 5.0% a year for 10 years, discounted at 10%, then 2.5% forever.
Sector median of 11.4x operating profit, less net debt. Banks have no EBITDA.
Dividend growing 5.5% a year against a 7.0% required return, from the stock’s beta.
The average of the method families that answered, not of the seven numbers: four of the seven start from the same earnings per share.
5 methods answered, across 4 families.
Room for errors in the reported numbers.
-18.5% from the average.
Models, not forecasts, and not investment advice. How each formula works →
Companies of similar size in Consumer Defensive, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| MDLZMondelez International, Inc. | $65.19 | 24.0x | 3.1x | 3.19% | 13.34% | $83.2B |
| TGTTarget Corp | $158.11 | 15.8x | 4.0x | 2.93% | 26.41% | $71.83B |
| MNSTMonster Beverage Corp | $47.30 | 43.8x | 9.9x | 0.00% | 25.70% | $92.66B |
| DEODiageo PLC | $96.69 | 31.0x | 89.1x | 2.07% | 14.98% | $53.77B |
| ABEVAmbev S.a | $3.33 | 17.5x | 2.9x | 0.69% | 18.40% | $51.34B |
| CCEPCOCA-COLA EUROPACIFIC PARTNERS plc | $114.23 | 22.1x | 5.4x | 2.11% | 23.54% | $50.2B |